InsidersTradesSigma
NextCell Pharma AB: insider trades · Finland · FIN-FSA
FI:nextcell-pharma-ab-72a6a9SE0009723125FI·FIN-FSAMcap 118M€Healthcare
Discover the full management transaction log of NextCell Pharma AB, a publicly traded company based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, NextCell Pharma AB has published 6 public disclosures. Market capitalisation: €118.3m. The latest transaction was disclosed on 3 June 2025 — Other. Among the most active insiders: Mathias Svahn. Every trade is accessible without an account.
6
Insider Decl.
0
Thresholds
€375
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
1.06 €
Analyst consensus
1 analysts3.50 €Target 3.50 €(+230%)3.50 €
Income statement
Revenue10.0 M€
Gross profit1.6 M€16% margin
Net income−39.4 M€-395.2% margin
Valuation
P/Book2.3x
Beta0.65
Balance sheet & cash
Market cap118.3 M€
Free Cash Flow−37.9 M€
Profitability & ownership
% insiders30.9%
% institutions6.6%
Last declaration on 3 June 2025
Declarations0 total
No declarations found
0 of 0 declarations